Treatment of Severe COVID-19 with Convalescent Plasma in the Bronx, NYC

Abstract Convalescent plasma with severe acute respiratory disease coronavirus 2 (SARS-CoV-2) antibodies (CCP) may hold promise as treatment for Coronavirus Disease 2019 (COVID-19). We compared the mortality and clinical outcome of patients with COVID-19 who received 200mL of CCP with a Spike protein IgG titer ≥1:2,430 (median 1:47,385) within 72 hours of admission to propensity score-matched controls cared for at a medical center in the Bronx, between April 13 to May 4, 2020. Matching criteria for controls were age, sex, body mass index, race, ethnicity, comorbidities, week of admission, oxygen requirement, D-dimer, lymphocyte counts, corticosteroids, and anticoagulation use. There was no difference in mortality or oxygenation between CCP recipients and controls at day 28. When stratified by age, compared to matched controls, CCP recipients <65 years had 4-fold lower mortality and 4-fold lower deterioration in oxygenation or mortality at day 28. For CCP recipients, pre-transfusion Spike protein IgG, IgM and IgA titers were associated with mortality at day 28 in univariate analyses. No adverse effects of CCP were observed. Our results suggest CCP may be beneficial for hospitalized patients <65 years, but data from controlled trials is needed to validate this finding and establish the effect of ageing on CCP efficacy..

Medienart:

Preprint

Erscheinungsjahr:

2022

Erschienen:

2022

Enthalten in:

bioRxiv.org - (2022) vom: 02. Dez. Zur Gesamtaufnahme - year:2022

Sprache:

Englisch

Beteiligte Personen:

Yoon, Hyun ah [VerfasserIn]
Bartash, Rachel [VerfasserIn]
Gendlina, Inessa [VerfasserIn]
Rivera, Johanna [VerfasserIn]
Nakouzi, Antonio [VerfasserIn]
Bortz, Robert H. [VerfasserIn]
Wirchnianski, Ariel S. [VerfasserIn]
Paroder, Monika [VerfasserIn]
Fehn, Karen [VerfasserIn]
Serrano-Rahman, Leana [VerfasserIn]
Babb, Rachelle [VerfasserIn]
Sarwar, Uzma N. [VerfasserIn]
Haslwanter, Denise [VerfasserIn]
Laudermilch, Ethan [VerfasserIn]
Florez, Catalina [VerfasserIn]
Dieterle, M. Eugenia [VerfasserIn]
Jangra, Rohit K. [VerfasserIn]
Fels, J. Maximilian [VerfasserIn]
Tong, Karen [VerfasserIn]
Mariano, Margarette C. [VerfasserIn]
Vergnolle, Olivia [VerfasserIn]
Georgiev, George I. [VerfasserIn]
Herrera, Natalia G. [VerfasserIn]
Malonis, Ryan J. [VerfasserIn]
Quiroz, Jose A. [VerfasserIn]
Morano, Nicholas C. [VerfasserIn]
Krause, Gregory J. [VerfasserIn]
Sweeney, Joseph M. [VerfasserIn]
Cowman, Kelsie [VerfasserIn]
Allen, Stephanie [VerfasserIn]
Annam, Jayabhargav [VerfasserIn]
Applebaum, Ariella [VerfasserIn]
Barboto, Daniel [VerfasserIn]
Khokhar, Ahmed [VerfasserIn]
Lally, Brianna J. [VerfasserIn]
Lee, Audrey [VerfasserIn]
Lee, Max [VerfasserIn]
Malaviya, Avinash [VerfasserIn]
Sample, Reise [VerfasserIn]
Yang, Xiuyi A. [VerfasserIn]
Li, Yang [VerfasserIn]
Ruiz, Rafael [VerfasserIn]
Thota, Raja [VerfasserIn]
Barnhill, Jason [VerfasserIn]
Goldstein, Doctor Y. [VerfasserIn]
Uehlinger, Joan [VerfasserIn]
Garforth, Scott J. [VerfasserIn]
Almo, Steven C. [VerfasserIn]
Lai, Jonathan R. [VerfasserIn]
Gil, Morayma Reyes [VerfasserIn]
Fox, Amy S. [VerfasserIn]
Chandran, Kartik [VerfasserIn]
Wang, Tao [VerfasserIn]
Daily, Johanna P. [VerfasserIn]
Pirofski, Liise-anne [VerfasserIn]

Links:

Volltext [kostenfrei]

Themen:

570
Biology

doi:

10.1101/2020.12.02.20242909

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

XBI019479638